pharmaceutical investing Pfizer Granted FDA Breakthrough Therapy Designation for 20-Valent Pneumococcal Conjugate Vaccine
pharmaceutical investing Rhythm Pharmaceuticals Completes Pivotal Enrollment in Two Ongoing Phase 3 Clinical Trials
Goldera Provides Update on 2026 Exploration Programs Targeting Multiple Gold Discovery Opportunities in Ontario and New Brunswick
Nevgold Files NI 43-101 Technical Report For Mineral Resource Estimate on the Limousine Butte Gold-Antimony Project, Nevada
